Functional relevance of biased signaling at the angiotensin ii type 1 receptor

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 11, Issue 2, 2011, Pages 99-111

  Tilley, Douglas G ^a,b  

^a Jefferson School of Pharmacy   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Apoptosis; AT1R; Biased signaling; Contractility; Hypertrophy; Internalization; Transactivation; arrestin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BETA ARRESTIN;

APOPTOSIS; ARTICLE; HUMAN; INTERNALIZATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 79956270842     PISSN: 18715303     EISSN: 18715303     Source Type: Journal    
DOI: 10.2174/187153011795564133     Document Type: Article

References (92)

1. Dorn, G. W.2nd. (2005) Physiologic growth and pathologic genes in cardiac development and cardiomyopathy. Trends Cardiovasc. Med., 15, 185-189.
2. Woodcock, E.A.; Grubb, D.R. and Iliades, P. Potential treatment of cardiac hypertrophy and heart failure by inhibiting the sarcolemmal binding of phospholipase Cbeta1b, Curr. Drug Targets., 11, 1032- 1040.
3. Hoogwerf, B.J. Renin-angiotensin system blockade and cardiovascular and renal protection, Am. J. Cardiol., 105, 30A- 50A.
4. Ma, T.K.; Kam, K.K.; Yan, B.P. and Lam, Y.Y. Renin-angiotensinaldosterone system blockade for cardiovascular diseases: current status, Br. J. Pharmacol., 160, 1273-1292.
5. Violin, J.D.; Dewire, S.M.; Yamashita, D.; Rominger, D.H.; Nguyen, L.; Schiller, K., Whalen, E.J.; Gowen, M. and Lark, M.W. (2010) Selectively engaging {beta}-arrestins at the AT1R reduces blood pressure and increases cardiac performance. J. Pharmacol. Exp. Ther., 335, 572-579.
6. Tilley, D.G.; Kim, I.M.; Patel, P.A.; Violin, J.D. and Rockman, H.A. (2009) beta-Arrestin mediates beta1-adrenergic receptorepidermal growth factor receptor interaction and downstream signaling. J. Biol. Chem., 284, 20375-20386.
7. DeWire, S.M.; Ahn, S.; Lefkowitz, R.J. and Shenoy, S.K. (2007) Beta-arrestins and cell signaling. Annu. Rev. Physiol., 69, 483-510.
8. Ahn, S.; Kim, J.; Hara, M.R.; Ren, X.R. and Lefkowitz, R.J. (2009) {beta}-Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation. J. Biol. Chem., 284, 8855-8865.
9. Rajagopal, K.; Whalen, E.J.; Violin, J.D.; Stiber, J.A.; Rosenberg, P.B.; Premont, R.T.; Coffman, T.M.; Rockman, H.A. and Lefkowitz, R.J. (2006) Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes. Proc. Natl. Acad. Sci. USA, 103, 16284-16289.
10. Kim, J.; Ahn, S.; Rajagopal, K. and Lefkowitz, R.J. (2009) Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. J. Biol. Chem., 284, 11953-11962.
11. DeWire, S.M.; Kim, J.; Whalen, E.J.; Ahn, S.; Chen, M. and Lefkowitz, R.J. (2008) Beta-arrestin-mediated signaling regulates protein synthesis. J. Biol. Chem., 283, 10611-10620.
12. Luttrell, L.M. and Lefkowitz, R.J. (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci., 115, 455-465.
13. Violin, J.D.; Dewire, S.M.; Barnes, W.G. and Lefkowitz, R.J. (2006) G protein-coupled receptor kinase and beta-arrestinmediated desensitization of the angiotensin II type 1A receptor elucidated by diacylglycerol dynamics. J. Biol. Chem., 281, 36411- 36419.
14. Miller, W.E.; Maudsley, S.; Ahn, S.; Khan, K.D.; Luttrell, L.M. and Lefkowitz, R.J. (2000) beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of betaarrestin1- dependent targeting of c-SRC in receptor endocytosis. J. Biol. Chem., 275, 11312-11319.
15. Laporte, S.A.; Oakley, R.H.; Zhang, J.; Holt, J.A.; Ferguson, S.S.; Caron, M.G. and Barak, L.S. (1999) The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci. USA, 96, 3712-3717.
16. Fessart, D.; Simaan, M. and Laporte, S.A. (2005) c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization. Mol. Endocrinol., 19, 491-503.
17. Fessart, D.; Simaan, M.; Zimmerman, B.; Comeau, J.; Hamdan, F.F.; Wiseman, P.W.; Bouvier, M. and Laporte, S.A. (2007) Srcdependent phosphorylation of beta2-adaptin dissociates the betaarrestin- AP-2 complex. J. Cell Sci., 120, 1723-1732.
18. Zimmerman, B.; Simaan, M.; Lee, M.H.; Luttrell, L.M. and Laporte, S.A. (2009) c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway. Cell Signal., 21, 103-110.
19. Claing, A.; Chen, W.; Miller, W.E.; Vitale, N.; Moss, J.; Premont, R.T. and Lefkowitz, R.J. (2001) beta-Arrestin-mediated ADPribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J. Biol. Chem., 276, 42509-42513.
20. Bouschet, T.; Martin, S.; Kanamarlapudi, V.; Mundell, S. and Henley, J.M. (2007) The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network. J. Cell Sci., 120, 2489-2497.
21. Poupart, M.E.; Fessart, D.; Cotton, M.; Laporte, S.A. and Claing, A. (2007) ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin. Cell Signal., 19, 2370-2378.
22. Shenoy, S.K. and Lefkowitz, R.J. (2005) Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J. Biol. Chem., 280, 15315-15324.
23. Shenoy, S.K.; Barak, L.S.; Xiao, K.; Ahn, S.; Berthouze, M.; Shukla, A.K.; Luttrell, L.M. and Lefkowitz, R.J. (2007) Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J. Biol. Chem., 282, 29549-29562.
24. Shenoy, S.K.; Xiao, K.; Venkataramanan, V.; Snyder, P.M.; Freedman, N.J. and Weissman, A.M. (2008) Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J. Biol. Chem., 283, 22166-22176.
25. Shenoy, S.K.; Modi, A.S.; Shukla, A.K.; Xiao, K.; Berthouze, M.; Ahn, S.; Wilkinson, K.D.; Miller, W.E. and Lefkowitz, R.J. (2009) Beta-arrestin-dependent signaling and trafficking of 7- transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc. Natl. Acad. Sci. USA, 106, 6650-6655.
26. Shukla, A.K.; Kim, J.; Ahn, S.; Xiao, K.; Shenoy, S.K.; Liedtke, W. and Lefkowitz, R.J. Arresting a transient receptor potential (TRP) channel: beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4. J. Biol. Chem., 285, 30115- 30125.
27. Li, H.; Li, H.F.; Felder, R.A.; Periasamy, A. and Jose, P.A. (2008) Rab4 and Rab11 coordinately regulate the recycling of angiotensin II type I receptor as demonstrated by fluorescence resonance energy transfer microscopy. J. Biomed. Opt., 13, 031206.
28. Esseltine, J.L.; Dale, L.B. and Ferguson, S.S. (2010) Rab GTPases bind at a common site within the angiotensin II type I receptor carboxyl-terminal tail: Evidence that Rab4 regulates receptor phosphorylation, desensitization and resensitization. Mol. Pharmacol., 79, 175-184
29. Tani, K.; Shibata, M.; Kawase, K.; Kawashima, H.; Hatsuzawa, K.; Nagahama, M. and Tagaya, M. (2003) Mapping of functional domains of gamma-SNAP. J. Biol. Chem., 278, 13531-13538.
30. Xiao, K.; McClatchy, D.B.; Shukla, A.K.; Zhao, Y.; Chen, M.; Shenoy, S.K.; Yates, J.R. 3rd and Lefkowitz, R.J. (2007) Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc. Natl. Acad. Sci. USA, 104, 12011-12016.
31. Tilley, D.G. and Rockman, H.A. (2006) Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment. Expert Rev. Cardiovasc. Ther., 4, 417- 432.
32. Patel, C.B.; Noor, N. and Rockman, H.A. (2010) Functional selectivity in adrenergic and angiotensin signaling systems, Mol. Pharmacol., 78, 983-992.
33. Luttrell, L.M.; Roudabush, F.L.; Choy, E.W.; Miller, W.E.; Field, M.E.; Pierce, K.L. and Lefkowitz, R.J. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. USA, 98, 2449-2454.
34. Meng, D.; Lynch, M.J.; Huston, E.; Beyermann, M.; Eichhorst, J.; Adams, D.R.; Klussmann, E.; Houslay, M.D. and Baillie, G.S. (2009) MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenalinestimulated internalization. J. Biol. Chem., 284, 11425-11435.
35. Song, X.; Coffa, S.; Fu, H. and Gurevich, V.V. (2009) How does arrestin assemble MAPKs into a signaling complex? J. Biol. Chem., 284, 685-695.
36. Tohgo, A.; Pierce, K.L.; Choy, E.W.; Lefkowitz, R.J. and Luttrell, L.M. (2002) beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem., 277, 9429-9436.
37. Ahn, S.; Shenoy, S.K.; Wei, H. and Lefkowitz, R.J. (2004) Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem., 279, 35518-35525.
38. Ahn, S.; Wei, H.; Garrison, T.R. and Lefkowitz, R.J. (2004) Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2. J. Biol. Chem., 279, 7807-7811.
39. Kim, J.; Zhang, L.; Peppel, K.; Wu, J.H.; Zidar, D.A.; Brian, L.; DeWire, S.M.; Exum, S.T.; Lefkowitz, R.J. and Freedman, N.J. (2008) Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. Circ. Res., 103, 70-79.
40. Perry, S.J.; Baillie, G.S.; Kohout, T.A.; McPhee, I.; Magiera, M.M.; Ang, K.L.; Miller, W.E.; McLean, A.J.; Conti, M.; Houslay, M.D. and Lefkowitz, R.J. (2002) Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science, 298, 834-836.
41. Nelson, C.D.; Kovacs, J.J.; Nobles, K.N.; Whalen, E.J. and Lefkowitz, R.J. (2008) Beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Ialpha promotes agoniststimulated sequestration of the beta2-adrenergic receptor. J. Biol. Chem., 283, 21093-21101.
42. Nelson, C.D.; Perry, S.J.; Regier, D.S.; Prescott, S.M.; Topham, M.K. and Lefkowitz, R.J. (2007) Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins, Science, 315, 663-666.
43. Xiao, K.; Sun, J.; Kim, J.; Rajagopal, S.; Zhai, B.; Villen, J.; Haas, W.; Kovacs, J.J.; Shukla, A.K.; Hara, M.R.; Hernandez, M.; Lachmann, A.; Zhao, S.; Lin, Y.; Cheng, Y.; Mizuno, K.; Ma'ayan, A.; Gygi, S.P. and Lefkowitz, R.J. Global phosphorylation analysisof beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc. Natl. Acad. Sci. USA, 107, 15299-15304.
44. Christensen, G.L.; Kelstrup, C.D.; Lyngso, C.; Sarwar, U.; Bogebo, R.; Sheikh, S.P.; Gammeltoft, S.; Olsen, J.V. and Hansen, J.L. Quantitative phosphoproteomics dissection of seventransmembrane receptor signaling using full and biased agonists. Mol. Cell Proteomics, 9, 1540-1553.
45. Wei, H.; Ahn, S.; Shenoy, S.K.; Karnik, S.S.; Hunyady, L.; Luttrell, L.M. and Lefkowitz, R.J. (2003) Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. USA, 100, 10782-10787.
46. Morinelli, T.A.; Kendall, R.T.; Luttrell, L.M.; Walker, L.P. and Ullian, M.E. (2009) Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation. J. Pharmacol. Exp. Ther., 330, 118-124.
47. Eguchi, S.; Numaguchi, K.; Iwasaki, H.; Matsumoto, T.; Yamakawa, T.; Utsunomiya, H.; Motley, E.D.; Kawakatsu, H.; Owada, K.M.; Hirata, Y.; Marumo, F. and Inagami, T. (1998) Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogenactivated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem., 273, 8890-8896.
48. Voisin, L.; Foisy, S.; Giasson, E.; Lambert, C.; Moreau, P. and Meloche, S. (2002) EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors. Am. J. Physiol. Cell Physiol., 283, C446-C455.
49. Seta, K. and Sadoshima, J. (2003) Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin IIinduced trans-activation of the epidermal growth factor receptor. J. Biol. Chem., 278, 9019-9026.
50. Shah, B.H.; Yesilkaya, A.; Olivares-Reyes, J.A.; Chen, H.D.; Hunyady, L. and Catt, K.J. (2004) Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor. Mol. Endocrinol., 18, 2035-2048.
51. Mifune, M.; Ohtsu, H.; Suzuki, H.; Nakashima, H.; Brailoiu, E.; Dun, N.J.; Frank, G.D.; Inagami, T.; Higashiyama, S.; Thomas, W.G.; Eckhart, A.D.; Dempsey, P.J. and Eguchi, S. (2005) G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J. Biol. Chem., 280, 26592-26599.
52. Zhai, P.; Galeotti, J.; Liu, J.; Holle, E.; Yu, X.; Wagner, T. and Sadoshima, J. (2006) An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Circ. Res., 99, 528-536.
53. Yano, N.; Suzuki, D.; Endoh, M.; Zhao, T.C.; Padbury, J.F. and Tseng, Y.T. (2007) A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells. J. Biol. Chem., 282, 18819-18830.
54. Ohtsu, H.; Higuchi, S.; Shirai, H.; Eguchi, K.; Suzuki, H.; Hinoki, A.; Brailoiu, E.; Eckhart, A.D.; Frank, G.D. and Eguchi, S. (2008) Central role of Gq in the hypertrophic signal transduction of angiotensin II in vascular smooth muscle cells. Endocrinology, 149, 3569-3575.
55. Itabashi, H.; Maesawa, C.; Oikawa, H.; Kotani, K.; Sakurai, E.; Kato, K.; Komatsu, H.; Nitta, H.; Kawamura, H.; Wakabayashi, G. and Masuda, T. (2008) Angiotensin II and epidermal growth factor receptor cross-talk mediated by a disintegrin and metalloprotease accelerates tumor cell proliferation of hepatocellular carcinoma cell lines. Hepatol. Res., 38, 601-613.
56. Olson, E.R.; Shamhart, P.E.; Naugle, J.E. and Meszaros, J.G. (2008) Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts, Hypertension, 51, 704-711.
57. Arellano-Plancarte, A.; Hernandez-Aranda, J.; Catt, K.J. and Olivares-Reyes, J.A. Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells. Biochem. Pharmacol., 79, 733-745.
58. Mugabe, B.E.; Yaghini, F.A.; Song, C.Y.; Buharalioglu, C.K.; Waters, C.M. and Malik, K.U. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation. J. Pharmacol. Exp. Ther., 332, 116-124.
59. Rakesh, K.; Yoo, B.; Kim, I.M.; Salazar, N.; Kim, K.S. and Rockman, H.A. (2010) beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. Sci. Signal., 3, ra46.
60. Freeman, E.J.; Sheakley, M.L. and Clements, R.J. (2010) Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A(2)-mediated release of arachidonic acid. Arch. Biochem. Biophys., 498, 50-56.
61. Buvinic, S.; Bravo-Zehnder, M.; Boyer, J.L.; Huidobro-Toro, J.P. and Gonzalez, A. (2007) Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells. J. Cell Sci., 120, 4289-4301.
62. Drube, S.; Stirnweiss, J.; Valkova, C. and Liebmann, C. (2006) Ligand-independent and EGF receptor-supported transactivation: lessons from beta2-adrenergic receptor signalling. Cell Signal., 18, 1633-1646.
63. Maudsley, S.; Pierce, K.L.; Zamah, A.M.; Miller, W.E.; Ahn, S.; Daaka, Y.; Lefkowitz, R.J. and Luttrell, L.M. (2000) The beta(2)- adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J. Biol. Chem., 275, 9572-9580.
64. Noma, T.; Lemaire, A.; Naga Prasad, S.V.; Barki-Harrington, L.; Tilley, D.G.; Chen, J.; Le Corvoisier, P.; Violin, J.D.; Wei, H.; Lefkowitz, R.J. and Rockman, H.A. (2007) Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J. Clin. Invest., 117, 2445-2458.
65. Elton, T.S. and Martin, M.M. (2003) Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor. Trends Endocrinol. Metab., 14, 66-71.
66. Zhou, Y.; Chen, Y.; Dirksen, W.P.; Morris, M. and Periasamy, M. (2003) AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ. Res., 93, 1089-1094.
67. van Esch, J.H.; Gembardt, F.; Sterner-Kock, A.; Heringer-Walther, S.; Le, T.H.; Lassner, D.; Stijnen, T.; Coffman, T.M.; Schultheiss, H.P.; Danser, A.H. and Walther, T. Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts. Cardiovasc. Res., 86, 401-409.
68. Elton, T.S. and Martin, M.M. (2007) Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms. Hypertension, 49, 953-961.
69. Boettger, T.; Beetz, N.; Kostin, S.; Schneider, J.; Kruger, M.; Hein, L. and Braun, T. (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest., 119, 2634-2647.
70. McDonald, O.G. and Owens, G.K. (2007) Programming smooth muscle plasticity with chromatin dynamics. Circ. Res., 100, 1428-1441.
71. Escano, C.S.Jr.; Keever, L.B.; Gutweiler, A.A. and Andresen, B.T. (2008) Angiotensin II activates extracellular signal-regulated kinase independently of receptor tyrosine kinases in renal smooth muscle cells: implications for blood pressure regulation. J. Pharmacol. Exp. Ther., 324, 34-42.
72. Andresen, B.T.; Linnoila, J.J.; Jackson, E.K. and Romero, G.G. (2003) Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Hypertension, 41, 781-786.
73. McEwen, S.T.; Balus, S.F.; Durand, M.J. and Lombard, J.H. (2009) Angiotensin II maintains cerebral vascular relaxation via EGF receptor transactivation and ERK1/2. Am. J. Physiol. Heart Circ. Physiol., 297, H1296-H1303.
74. Lee, M.H.; El-Shewy, H.M.; Luttrell, D.K. and Luttrell, L.M. (2008) Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription. J. Biol. Chem., 283, 2088-2097.
75. Christensen, G.L.; Knudsen, S.; Schneider, M.; Aplin, M.; Gammeltoft, S.; Sheikh, S.P. and Hansen, J. L. (2010) AT(1) receptor Galphaq protein-independent signalling transcriptionally activates only a few genes directly, but robustly potentiates gen regulation from the beta2-adrenergic receptor. Mol. Cell Endocrinol., 331, 49-56
76. Lorenz, K.; Schmitt, J.P.; Vidal, M. and Lohse, M.J. (2009) Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling, Int. J. Biochem. Cell Biol., 41, 2351-2355.
77. Barki-Harrington, L.; Luttrell, L.M. and Rockman, H.A. (2003) Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation, 108, 1611-1618.
78. Cervantes, D.; Crosby, C. and Xiang, Y. (2010) Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK. Circ. Res., 106, 79-88.
79. Revankar, C.M.; Vines, C.M.; Cimino, D.F. and Prossnitz, E.R. (2004) Arrestins block G protein-coupled receptor-mediated apoptosis. J. Biol. Chem., 279, 24578-24584.
80. Endoh, M. (2008) Cardiac Ca2+ signaling and Ca2+ sensitizers. Circ. J., 72, 1915-1925.
81. Barnes, W.G.; Reiter, E.; Violin, J.D.; Ren, X.R.; Milligan, G. and Lefkowitz, R.J. (2005) beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J. Biol. Chem., 280, 8041-8050.
82. Godin, C.M. and Ferguson, S.S. The angiotensin II type 1 receptor induces membrane blebbing by coupling to Rho A, Rho kinase, and myosin light chain kinase. Mol. Pharmacol., 77, 903-911.
83. Worzfeld, T.; Wettschureck, N. and Offermanns, S. (2008) G(12)/G(13)-mediated signalling in mammalian physiology and disease. Trends Pharmacol. Sci., 29, 582-589.
84. Tilley, D.G.; Nguyen, A.D. and Rockman, H.A. (2010) Troglitazone stimulates beta-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor. Biochem. Biophys. Res. Commun., 396, 921-926.
85. Aplin, M.; Christensen, G.L.; Schneider, M.; Heydorn, A.; Gammeltoft, S.; Kjolbye, A.L.; Sheikh, S.P. and Hansen, J.L. (2007) The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and - independent pathways in cardiac myocytes and langendorffperfused hearts. Basic Clin. Pharmacol. Toxicol., 100, 289-295.
86. Sanni, S.J.; Hansen, J.T.; Bonde, M.M.; Speerschneider, T.; Christensen, G.L.; Munk, S.; Gammeltoft, S. and Hansen, J.L. (2010) beta-Arrestin 1 and 2 stabilize the angiotensin II type I receptor in distinct high-affinity conformations. Br. J. Pharmacol., 161, 150-161.
87. Kim, J.; Ahn, S.; Ren, X.R.; Whalen, E.J.; Reiter, E.; Wei, H. and Lefkowitz, R.J. (2005) Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc. Natl. Acad. Sci. USA, 102, 1442-1447.
88. Penela, P.; Murga, C.; Ribas, C.; Tutor, A.S.; Peregrin, S. and Mayor, F.Jr. (2006) Mechanisms of regulation of G proteincoupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc. Res., 69, 46-56.
89. Gros, R.; Chorazyczewski, J.; Meek, M.D.; Benovic, J.L.; Ferguson, S.S. and Feldman, R.D. (2000) G-Protein-coupled receptor kinase activity in hypertension: increased vascular and lymphocyte G-protein receptor kinase-2 protein expression. Hypertension, 35, 38-42.
90. Izzo, R.; Cipolletta, E.; Ciccarelli, M.; Campanile, A.; Santulli, G.; Palumbo, G.; Vasta, A.; Formisano, S.; Trimarco, B. and Iaccarino, G. (2008) Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. Clin. Transl. Sci., 1, 215-220.
91. Schutzer, W.E.; Reed, J.F.; Bliziotes, M. and Mader, S.L. (2001) Upregulation of G protein-linked receptor kinases with advancing age in rat aorta. Am. J. Physiol. Regul. Integr. Comp. Physiol., 280, R897-R903.
92. Shukla, A.K.; Violin, J.D.; Whalen, E.J.; Gesty-Palmer, D.; Shenoy, S.K. and Lefkowitz, R.J. (2008) Distinct conformational changes in beta-arrestin report biased agonism at seventransmembrane receptors. Proc. Natl. Acad. Sci. USA, 105, 9988-9993.